Here we present data showing that the molecular basis for at least part of the anti-tumor activity by ABR-217620 resides in the distinct interaction between the T lymphocyte membrane protein TRBV7-9 and the Sag SEA/E-120 in the fusion protein bound to the 5T4 antigen on tumor cells. This evidence concerns the gene TRBV7-9 and neoplasm.